Fortrea Holdings (FTRE) Capital Expenditures (2022 - 2026)
Fortrea Holdings (FTRE) reported Capital Expenditures of $8.0 million for Q1 2026, up 175.86% on a YoY basis from $2.9 million in Q1 2025, and up 6.67% quarter-over-quarter from $7.5 million in Q4 2025.
Fortrea Holdings (FTRE) Capital Expenditures (2022 - 2026) Analysis & Trends
Fortrea Holdings has reported Capital Expenditures for 5 years, with the latest figure at $8.0 million in Q1 2026.
- For the quarter ending Q1 2026, Capital Expenditures rose 175.86% year-over-year to $8.0 million; the trailing twelve-month figure through Mar 2026 stood at $30.3 million (up 58.64% YoY), and the FY2025 full-year result was $25.2 million, down 1.18% from the prior year.
- Capital Expenditures for Q1 2026 stood at $8.0 million, up from $7.5 million in the prior quarter.
- The five-year high for Capital Expenditures was $18.4 million in Q4 2022, with the low at -$3.2 million in Q4 2024.
- Historically, Capital Expenditures has averaged $9.0 million across 5 years, with a median of $8.2 million in 2024.
- Annual changes were most pronounced in 2024 — Capital Expenditures tumbled 134.04% — and 2025, when it jumped 334.38%.
- Fortrea Holdings' Capital Expenditures stood at $18.4 million in 2022, then tumbled by 48.91% to $9.4 million in 2023, then plunged by 134.04% to -$3.2 million in 2024, then jumped by 334.38% to $7.5 million in 2025, then advanced by 6.67% to $8.0 million in 2026.
- The last three Capital Expenditures figures came in at $8.0 million (Q1 2026), $7.5 million (Q4 2025), and $7.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 133.40 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -63,220.27 |
| 10 | Fortrea Holdings | 1.43 Bn | 1.28 Bn | 123.60 Mn | 8.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.00 Mn |
| Mar 31, 2026 | 8.00 Mn |
| Dec 31, 2025 | 7.50 Mn |
| Dec 31, 2025 | 7.50 Mn |
| Sep 30, 2025 | 7.30 Mn |
| Sep 30, 2025 | 7.30 Mn |
| Jun 30, 2025 | 7.50 Mn |
| Jun 30, 2025 | 7.50 Mn |
| Mar 31, 2025 | 2.90 Mn |
| Mar 31, 2025 | 2.90 Mn |
| Dec 31, 2024 | -3.20 Mn |
| Dec 31, 2024 | -3.20 Mn |
| Sep 30, 2024 | 8.20 Mn |
| Sep 30, 2024 | 8.20 Mn |
| Jun 30, 2024 | 11.20 Mn |
| Jun 30, 2024 | 11.20 Mn |
| Mar 31, 2024 | 9.30 Mn |
| Mar 31, 2024 | 9.30 Mn |
| Dec 31, 2023 | 9.40 Mn |
| Dec 31, 2023 | 9.40 Mn |